Terawulf [WULF] vs Morgan Stanley [MS] Detailed Stock Comparison

Terawulf Inc.

NASDAQ
Loading...

Morgan Stanley

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Terawulf Inc. wins in 3 metrics, Morgan Stanley wins in 14 metrics, with 0 ties. Morgan Stanley appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Terawulf Inc. Morgan Stanley Better
P/E Ratio (TTM) -12.27 17.31 Morgan Stanley
Price-to-Book Ratio 60.78 2.97 Morgan Stanley
Debt-to-Equity Ratio 3,699.47 455.75 Morgan Stanley
PEG Ratio 5,075.00 0.53 Morgan Stanley
EV/EBITDA -127.56 N/A N/A
Profit Margin (TTM) 50.93% 24.75% Terawulf Inc.
Operating Margin (TTM) -210.53% 40.62% Morgan Stanley
EBITDA Margin (TTM) N/A 40.62% N/A
Return on Equity -343.69% 14.42% Morgan Stanley
Return on Assets (TTM) -2.55% 1.14% Morgan Stanley
Free Cash Flow (TTM) $-1.18B $-20.79B Terawulf Inc.
Dividend Yield N/A 2.15% N/A
1-Year Return 548.26% 65.29% Terawulf Inc.
Price-to-Sales Ratio (TTM) 59.04 4.15 Morgan Stanley
Enterprise Value $10.31B $225.65B Morgan Stanley
EV/Revenue Ratio 61.22 3.08 Morgan Stanley
Gross Profit Margin (TTM) 47.28% N/A N/A
Revenue per Share (TTM) $0 $47 Morgan Stanley
Earnings per Share (Diluted) $-1.66 $11.04 Morgan Stanley
Beta (Stock Volatility) 4.26 1.18 Morgan Stanley
Short % of Float 28.35% 0.00% Morgan Stanley

Terawulf Inc. vs Morgan Stanley Stock Performance Analysis

Loading Price Chart...

WULF
MS

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Terawulf Inc.8.10%8.93%26.21%71.66%125.54%121.11%
Morgan Stanley1.84%2.70%13.23%40.00%22.61%19.84%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Terawulf Inc.548.26%1,684.93%149.86%144.92%206.59%206.59%
Morgan Stanley65.29%142.98%154.54%745.67%837.54%275.57%

Performance & Financial Health Analysis: Terawulf Inc. vs Morgan Stanley

MetricWULFMS
Market Information
Market Cap i$9.98B$299.55B
Market Cap CategoryMid capMega cap
10 Day Avg. Volume i34,397,3756,501,123
90 Day Avg. Volume i31,349,8186,965,138
Last Close$28.17$217.98
52 Week Range$3.40 - $28.44$129.66 - $220.60
% from 52W High-0.97%-1.19%
All-Time High$43.98 (Nov 15, 2021)$220.60 (Jun 15, 2026)
% from All-Time High-35.95%-1.19%
Growth Metrics
Quarterly Revenue Growth0.02%0.16%
Quarterly Earnings Growth0.02%0.29%
Financial Health
Profit Margin (TTM) i0.51%0.25%
Operating Margin (TTM) i-2.11%0.41%
Return on Equity (TTM) i-3.44%0.14%
Debt to Equity (MRQ) i3,699.47455.75
Cash & Liquidity
Book Value per Share (MRQ)$0.33$64.37
Cash per Share (MRQ)$7.70$379.99
Operating Cash Flow (TTM) i$-123,180,000$-95,740,000,000
Levered Free Cash Flow (TTM) i$-113,667,752$16.25B
Dividends
Last 12-Month Dividend Yield iN/A2.15%
Last 12-Month Dividend i$0.00$3.93

Valuation & Enterprise Metrics Analysis: Terawulf Inc. vs Morgan Stanley

MetricWULF (Apr 24, 2026)MS (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-12.2717.31
Forward P/E i5,075.0015.16
PEG Ratio i5,075.000.53
Price to Sales (TTM) i59.044.15
Price to Book (MRQ) i60.782.97
Market Capitalization
Market Capitalization i$9.98B$299.55B
Enterprise Value i$10.31B$225.65B
Enterprise Value Metrics
Enterprise to Revenue i61.223.08
Enterprise to EBITDA i-127.56N/A
Risk & Other Metrics
Beta i4.261.18
Book Value per Share (MRQ) i$0.33$64.37

Financial Statements Comparison: Terawulf Inc. vs Morgan Stanley

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricWULF (2025)MS (2025)
Revenue/Sales i168.46M65.97B
Cost of Goods Sold i82.66MN/A
COGS % of Revenue i49.1%0.0%
Gross Profit i85.79MN/A
Gross Margin i50.9%0.0%
Research & Development iN/AN/A
Operating Income (EBIT) i-170.31MN/A
Operating Margin i-101.1%0.0%
EBITDA i-38.82MN/A
EBITDA Margin i-23.0%0.0%
Pre-Tax Income i-657.21M21.95B
Pre-Tax Income % of Revenue i-390.1%33.3%
Income Tax i76,0004.93B
Income Tax % of Revenue i0.0%7.5%
Net Income (Profit) i-661.42M17.03B
Profit Margin i-392.6%25.8%

Balance Sheet & Liquidity Metrics

MetricWULF (2025)MS (2025)
Cash & Equivalents i3.27B81.31B
Total Current Assets i3.48BN/A
Total Current Assets % of Revenue i2,064.8%0.0%
Total Current Liabilities i1.74BN/A
Total Current Liabilities % of Revenue i1,030.5%0.0%
Long-Term Debt i4.66B349.39B
Long-Term Debt % of Revenue i2,764.9%529.7%
Total Shareholders Equity i140.45M112.65B
Retained Earnings i-993.69M115.09B
Retained Earnings % of Revenue i-589.9%174.5%
Property, Plant & Equipment i528.13M20.00M

Cash Flow Statement Comparison

MetricWULF (2025)MS (2025)
Operating Cash Flow i-626.30M-95.74B
Operating Cash Flow % of Revenue i-371.8%-145.1%
Capital Expenditures i-1.05B-2.90B
Free Cash Flow i-1.18B-20.79B
FCF Margin i-702.5%-31.5%
Debt Repayment i-9.16M-99.39B
Common Stock Repurchase i-33.30M-5.84B

Short Interest & Institutional Ownership Analysis

MetricWULFMS
Shares Short i98.36M13,702
Short Ratio i3.360.00
Short % of Float i28.35%0.00%
Shares Outstanding i420.07M1.58B
Float Shares i324.37M1.20B
% Held by Insiders i23.18%24.27%
% Held by Institutions i72.58%63.01%
% Held by Public i4.24%12.72%

Dividend Analysis & Yield Comparison: Terawulf Inc. vs Morgan Stanley

MetricWULFMS
Last 12-Month Dividend i$0.00$3.93
Last 12-Month Dividend Yield iN/A2.15%
3-Year Avg Annual Dividend i$0.00$3.63
3-Year Avg Dividend Yield iN/A0.83%
3-Year Total Dividends i$0.00$10.90
Ex-Dividend DateN/AJan 30, 2026